(Date:11/26/2009)... Research Triangle Dental (...ral North Carolina, today announced the expansion ...d LUMINEER Dentist, Dr. Doug Macmillan. , ... Triangle Dental is pleased to announce that Dr. D... recently completed an additional advanced trainin...
(Date:11/25/2009)...,, KANSASCITY,Mo.,Nov.25/PRNewswire/--TheBartle...,slargestmedicalcliniconDec.9-10,whenKansasCityhos...edpeople. ,, "Thisfreecliniceventhasthepotentia...ysinsteadofjustoneandbeheldonweekdaysinsteadofover...tyFreeHealthClinicandpresidentoftheNationalAssocia...
(Date:11/25/2009)...,, LONGBEACH,Calif.,Nov.25/PRNewswire/--Thanksg...oundseniorsinthegreaterLongBeachareathankstoFaithI...IndependenceatHome(IAH),adivisionofSCANHealthPlan....ndredsofvolunteerstodeliverwarmThanksgivingmealsto...Bay,SouthLosAngelesandsurroundingcities. ,, "Ou...
(Date:11/25/2009)...,, BroadPoliticalEndorsements,Business,andPres...RNewswire-USNewswire/--Onceagain,theNationalBipola...amationendorsingtheir"Safe,tilStable"program,which...sureforbipolardisorder.Today,theNationalBipolarFou...lExpressPriorityMailfromtheLt.GovernorofLouisianaM...
(Date:11/25/2009)...Does stress increase blood pressure? This simple ...r many years. New Stress-related gene Modulates H...rease blood pressure? This simple question has be...Now new research has for the first time establishe...blood pressure response to stress in mice as well ...
Breaking Medicine News(10 mins):Health News:Dr. Douglas Macmillan Now Providing LUMINEERS at Research Triangle Dental 2Health News:Kansas City Prepares for Largest Free Health Clinic 2Health News:SCAN Employees and Community Volunteers to Help Deliver One Thousand Thanksgiving Meals to Homebound Seniors 2Health News:First Time-Door is Open for Family Discussion of Bipolar Disorder 2Health News:First Time-Door is Open for Family Discussion of Bipolar Disorder 3Health News:New stress-related gene modulates high blood pressure in mice and men 2(Date:11/25/2009)...Newswire-FirstCall/--Pharmasset,Inc.(Nasdaq: VRUS ...scovering,developingandcommercializingnoveldrugsto...efiscalyearendedSeptember30,2009.AtSeptember30,200...ndshortterminvestments. ,, PipelineUpdateand20... ,, InlateNovember2009,anindependentDataMonito...
(Date:11/25/2009)...ire/--BioTrendsResearchGroup,Inc.releasedWave1ofit...amulti-phasesyndicatedmarketresearchprojecttrackin...ductlaunchthroughthefirstsixmonthsofavailability.E...rom75uniqueDermatologistsandqualitativeinformation...ra,obstaclestouse,typicalpatienttypes,productperce...
(Date:11/25/2009)...RNewswire-USNewswire/--RemediumTechnologiesInc.,ac...erebleeding,wonfirstprizeand$10,000intheMostPromis...e2009,companyofficialsannouncetoday. ,, Selecte...,steampitchedtheirinventionattheGSCSecuritySummitc...medium( www.remediumtechnologies.com )isdeveloping...
Breaking Medicine Technology:Pharmasset Reports Fiscal Year End 2009 Financial Results 2Pharmasset Reports Fiscal Year End 2009 Financial Results 3Pharmasset Reports Fiscal Year End 2009 Financial Results 4Pharmasset Reports Fiscal Year End 2009 Financial Results 5Pharmasset Reports Fiscal Year End 2009 Financial Results 6Pharmasset Reports Fiscal Year End 2009 Financial Results 7Pharmasset Reports Fiscal Year End 2009 Financial Results 8Despite Managed Care Obstacles, Interest and Anticipated Use of Centocor Ortho-Biotech's New Psoriasis Agent Stelara (ustekinumab) is High 2Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam 2Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam 3Shire Builds Competitive Position of its HGT Business through Research Collaboration with Santaris Pharma A S on LNA Drug Platform 13659 1Shire Builds Competitive Position of its HGT Business through Research Collaboration with Santaris Pharma A S on LNA Drug Platform 13659 2Shire Builds Competitive Position of its HGT Business through Research Collaboration with Santaris Pharma A S on LNA Drug Platform 13659 3Shire Builds Competitive Position of its HGT Business through Research Collaboration with Santaris Pharma A S on LNA Drug Platform 13659 4Bavarian Nordic in Negotiations With the US Authorities for the Further Development of IMVAMUNE 28R 29 13656 1Bavarian Nordic in Negotiations With the US Authorities for the Further Development of IMVAMUNE 28R 29 13656 2Santaris Pharma A S Forms Strategic Alliance With Shire plc to Develop RNA Based Medicines for the Treatment of Rare Genetic Disorders 13655 1Santaris Pharma A S Forms Strategic Alliance With Shire plc to Develop RNA Based Medicines for the Treatment of Rare Genetic Disorders 13655 2Santaris Pharma A S Forms Strategic Alliance With Shire plc to Develop RNA Based Medicines for the Treatment of Rare Genetic Disorders 13655 3Santaris Pharma A S Forms Strategic Alliance With Shire plc to Develop RNA Based Medicines for the Treatment of Rare Genetic Disorders 13655 4...SAN MATEO, Calif., Jan. 8 Corthera Inc. today ann...hase II clinical trial of,Relaxin, a naturally occ...,acute heart failure and other acute care illnesse...afety of Relaxin in,patients with acute heart fail...from more than 50 investigational centers worldwid...
...DEERFIELD, Ill., Jan. 7 Baxter International,Inc....ed pre-clinical,programs to develop recombinant Fa...l develop both an unmodified recombinant Factor IX...and a chemically modified, long-acting,version of ...leeding in,hemophilia B patients. Hemophilia B is ...
Other Medicine Technology:Corthera Initiates Phase II Clinical Trial of Relaxin in Acute Heart Failure 2Baxter Announces Recombinant Factor IX Development Program For Hemophilia B 2Baxter Announces Recombinant Factor IX Development Program For Hemophilia B 3APEX™ Nitinol Flat Wire Basket
HALO™ Nitinol Tipless Stone Basket
Agglutinating Sera
ProSpecT Shiga Toxin E. coli (STEC) Microplate Assay
Medicine Products: